Technical Analysis for PTEO - Proteo, Inc

Grade Last Price % Change Price Change
grade F 0.0462 -1.70% -0.0008
PTEO closed down 1.7 percent on Tuesday, December 3, 2019, on 8 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Very Strong N/A Down Down
See historical PTEO trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
50 DMA Resistance Bearish -1.70%
Fell Below 20 DMA Bearish -1.70%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.70%
Wide Bands Range Expansion -1.70%
Older signals for PTEO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Proteo, Inc. is a clinical-stage drug development company. The Company intends to develop, promote and market pharmaceuticals and other biotech products. The Company's focus is on the development of anti-inflammatory treatments for rare diseases with unmet needs. The Company is engaged in the development of pharmaceuticals based on the body's own tools and weapons to fight inflammatory diseases. The Company is focusing its research on the development of drugs based on the human protein, Elafin. The Company has obtained Orphan drug designations within the European Union for the use of Elafin for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension, as well as for the treatment of esophageal cancer. Within the United States, it has obtained Orphan drug designations for the use of Elafin for the treatment of pulmonary arterial hypertension, as well as for the prevention of inflammatory complications of transthoracic esophagectomy.
Health Pharmaceuticals Life Sciences European Union Hypertension Drug Development Rare Diseases Inflammatory Diseases Pulmonary Arterial Hypertension Pulmonary Hypertension Esophageal Cancer

Is PTEO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 0.349
52 Week Low 0.01
Average Volume 73,406
200-Day Moving Average 0.0000
50-Day Moving Average 0.0631
20-Day Moving Average 0.0539
10-Day Moving Average 0.0521
Average True Range 0.0210
ADX 55.13
+DI 47.1272
-DI 12.0725
Chandelier Exit (Long, 3 ATRs ) 0.0799
Chandelier Exit (Short, 3 ATRs ) 0.1030
Upper Bollinger Band 0.0826
Lower Bollinger Band 0.0252
Percent B (%b) 0.37
BandWidth 106.4935
MACD Line -0.0029
MACD Signal Line -0.0027
MACD Histogram -0.0002
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0537
Resistance 3 (R3) 0.0545 0.0529 0.0525
Resistance 2 (R2) 0.0529 0.0510 0.0525 0.0520
Resistance 1 (R1) 0.0495 0.0498 0.0487 0.0487 0.0516
Pivot Point 0.0479 0.0479 0.0475 0.0475 0.0479
Support 1 (S1) 0.0445 0.0460 0.0437 0.0437 0.0408
Support 2 (S2) 0.0429 0.0448 0.0425 0.0404
Support 3 (S3) 0.0395 0.0429 0.0400
Support 4 (S4) 0.0387